CG
LSTA icon

Cutler Group’s Lisata Therapeutics LSTA Stock Holding History

Cutler Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66
Closed – – 4875
2022
Q3 		$0 Sell
66
-1
-1% -$7 ﹤0.01% 5257
2022
Q2 		$0 Hold
67
– – ﹤0.01% 5374
2022
Q1 		$0 Hold
67
– – ﹤0.01% 5729
2021
Q4 		$0 Hold
67
– – ﹤0.01% 5783
2021
Q3 		$1K Hold
67
– – ﹤0.01% 5349
2021
Q2 		$1K Hold
67
– – ﹤0.01% 5339
2021
Q1 		$1K Buy
67
+40
+148% +$1.21K ﹤0.01% 5275
2020
Q4 		$0 Hold
27
– – ﹤0.01% 5207
2020
Q3 		$0 Buy
+27
New +$854 ﹤0.01% 5016

Other funds holding LSTA

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cutler Group's LSTA Position: Q4 2022 in Review

Cutler Group sold out of Lisata Therapeutics (LSTA) in Q4 2022, closing a stake of 66 shares.

Cutler Group first reported a position in LSTA in Q3 2020 and held it in 9 quarters. The position peaked at $1K in Q3 2021. 24 funds tracked by Wall St. Rank hold LSTA as of Q4 2022.

  • Cutler Group reported no remaining Lisata Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 66 Lisata Therapeutics shares in Q4 2022.
  • Cutler Group first reported a position in Lisata Therapeutics in Q3 2020 and held it in 9 quarters.
  • Cutler Group's Lisata Therapeutics position peaked at $1K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.